Hear from the Cameron Prize winners at Pharmacology Futures 2026

Hear from the Cameron Prize winners at Pharmacology Futures 2026 

Professor Lotte Bjerre Knudsen, Dr Jesper Lau and Dr Thomas Kruse of Novo Nordisk have been awarded the 2026 Cameron Prize for Therapeutics of the University of Edinburgh for their pioneering work in the development of semaglutide, a treatment that has transformed clinical approaches to obesity. 

The University of Edinburgh has published the full announcement, recognising the trio’s central scientific contributions and the global impact of their work.  

Join us at Pharmacology Futures to hear from the prize winners 

As part of the award, Dr Jesper Lau and Dr Thomas Kruse will deliver the Cameron Prize lecture on 4 June 2026 at Pharmacology Futures — a major new event delivered in partnership by the University of Edinburgh, the British Pharmacological Society (BPS) and the Royal Society of Edinburgh (RSE). 

The lecture will offer attendees a rare opportunity to hear directly from two of the scientists behind one of the most significant therapeutic advances of recent years. Delegates will gain insights into: 

The Cameron Prize, a prestigious award with a long history 

The Cameron Prize, to be awarded by Professor David Argyle, Vice Principal and Head of the College of Medicine & Veterinary Medicine at the University of Edinburgh, is one of the most respected international honours in therapeutics. Its recipients include many figures who later went on to receive the Nobel Prize, reflecting its longstanding reputation for recognising groundbreaking contributions to medical science. 

What to expect from Pharmacology Futures 

Pharmacology Futures will explore the role pharmacology will play in transforming therapeutics over the next decade. The programme will cover: 

The conference also forms part of celebrations marking the 300th anniversary of the Edinburgh Medical School, bringing together leaders across science, medicine and industry to examine the future of the field.